These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Use of lysergic acid diethylamide in a psychotherapeutic setting. COHEN S; EISNER BG AMA Arch Neurol Psychiatry; 1959 May; 81(5):615-9. PubMed ID: 13636528 [No Abstract] [Full Text] [Related]
29. [Psycholytic interval therapy with LSD 25 or ambulant psychoanalytical therapy?]. Derbolowsky U Z Psychother Med Psychol; 1966 Jan; 16(1):33-8. PubMed ID: 5911900 [No Abstract] [Full Text] [Related]
30. [Psycholytic therapy: clinical psychotherapy with adjuvant LSD-25 and related substances]. LEUNER H Z Psychother Med Psychol; 1963 Mar; 13():57-64. PubMed ID: 13929988 [No Abstract] [Full Text] [Related]
31. [Psychotherapeutic possibilities for overcoming treatment resistance with special reference to a psycholytic method]. HEIN GW Z Psychother Med Psychol; 1963 May; 13():81-7. PubMed ID: 13953410 [No Abstract] [Full Text] [Related]
32. [Principles of psychotherapy under the influence of psycholytic agents]. BAROLIN GS Evol Psychiatr (Paris); 1962; 27():283-93. PubMed ID: 13865141 [No Abstract] [Full Text] [Related]
33. Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy. O'Donnell KC; Anderson BT; Barrett FS; Bogenschutz MP; Grob CS; Hendricks PS; Kelmendi B; Nayak SM; Nicholas CR; Paleos CA; Stauffer CS; Gukasyan N Am J Psychiatry; 2024 Jan; 181(1):74-75. PubMed ID: 38161295 [No Abstract] [Full Text] [Related]
34. D-lysergic acid in the treatment of the biological features of childhood schizophrenia. Bender L Dis Nerv Syst; 1966 Jul; 7 Suppl(7):43-6. PubMed ID: 5965284 [No Abstract] [Full Text] [Related]
35. [Pharmacotherapy and psychotherapy; LSD as an adjuvant in psychotherapy?]. Schuurman CJ Ned Tijdschr Geneeskd; 1968 Jun; 112(23):1095-6. PubMed ID: 5669627 [No Abstract] [Full Text] [Related]
36. Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey. Schindler EA; Gottschalk CH; Weil MJ; Shapiro RE; Wright DA; Sewell RA J Psychoactive Drugs; 2015; 47(5):372-81. PubMed ID: 26595349 [TBL] [Abstract][Full Text] [Related]
37. The role of mescaline and D-lysergic acid in psychiatric treatment. Malitz S Dis Nerv Syst; 1966 Jul; 7 Suppl(7):39-42. PubMed ID: 5965283 [No Abstract] [Full Text] [Related]
38. [Pharmacotherapy and psychotherapy. LSD as an adjuvant in psychotherapy?]. Booij J Ned Tijdschr Geneeskd; 1968 Jan; 112(1):2-7. PubMed ID: 5691284 [No Abstract] [Full Text] [Related]
39. The resolution and subsequent remobilization of resistance by LSD in psychotherapy. SAVAGE C J Nerv Ment Dis; 1957; 125(3):434-7. PubMed ID: 13481750 [No Abstract] [Full Text] [Related]